What Does Fibrocell Science Do?

Total employees12
HeadquartersExton
FoundedN/A

Fibrocell Science, Inc. was an autologous cell and gene therapy company dedicated to discovering and developing novel treatments for patients with rare and serious skin and connective tissue diseases. Their approach involved using a patient's own cells to create personalized therapies. The company's most notable product candidate was FCX-007 (dibereciclast) for recessive dystrophic epidermolysis bullosa (RDEB) and FCX-013 for localized scleroderma. In late 2019, Fibrocell Science was acquired by Castle Creek Pharmaceuticals (now Castle Creek Biosciences), a company focused on developing and commercializing innovative therapies for rare genetic skin and connective tissue disorders.

Where Is Fibrocell Science's Headquarters?

HQ Function

The headquarters served as the primary center for Fibrocell's research and development, clinical trial management, and corporate operations, focusing on advancing their gene therapy pipeline.

Notable Features:

As a biotech R&D facility, it likely housed specialized laboratories for cell culture, gene vector development, and analytical testing, crucial for their autologous therapy programs.

Work Culture:

The work culture at Fibrocell Science was likely characterized by a strong scientific focus, innovation-driven environment, and a patient-centric approach, typical of companies developing treatments for rare diseases.

HQ Significance:

This location was significant as the hub for Fibrocell's pioneering work in developing personalized cell and gene therapies for debilitating skin conditions before its assets and programs were integrated into Castle Creek Biosciences.

Values Reflected in HQ: The headquarters would have reflected values of scientific excellence, innovation in gene therapy, and a commitment to addressing unmet medical needs for patients with rare diseases.

Location:

Prior to its acquisition, Fibrocell Science's operations were primarily concentrated in the United States, focusing on research, development, and clinical trials. While they may have collaborated with international research institutions or CROs for specific trial sites, they did not maintain significant independent international offices. Their product candidates were targeted for US regulatory approval initially.

Street Address:

405 Eagleview Blvd

City:

Exton

State/Province:

Pennsylvania

Country:

USA

Where Else Does Fibrocell Science Operate Around the World?

No additional office locations available.

Buying Intent Signals for Fibrocell Science

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Fibrocell Science? Meet the Executive Team

As of April 2025, Fibrocell Science' leadership includes:

John Maslowski - Former President and Chief Executive Officer
Douglas J. Swirsky - Former Chief Financial Officer and Treasurer
John P. Schফিকnáník - Former Senior Vice President, General Counsel & Corporate Secretary
Bernd M. Wollschlaeger, M.D. - Former Chief Medical Officer

Who's Investing in Fibrocell Science?

Fibrocell Science has been backed by several prominent investors over the years, including:

OrbiMed
Pemaju Investments Pte Ltd
Intrexon Corporation (now Precigen)
Various public shareholders (as FCSC on NASDAQ)

What Leadership Changes Has Fibrocell Science Seen Recently?

Hire0
Exits0

As Fibrocell Science was acquired by Castle Creek Biosciences in late 2019 and ceased independent operations, there have been no executive hires or exits attributable to Fibrocell Science as an independent entity within the last 12 months. Any leadership changes would have occurred during the acquisition and integration process into Castle Creek Biosciences more than 12 months ago.

What Technology (Tech Stack) Is Used byFibrocell Science?

Discover the tools Fibrocell Science uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Fibrocell Science Email Formats and Examples

Prior to its acquisition, Fibrocell Science likely used common corporate email formats. The domain would have been fibrocell.com. Post-acquisition, these email addresses are no longer active.

[first_initial][last]@fibrocell.com

Format

jdoe@fibrocell.com

Example

0 (Company acquired, email domain likely inactive)%

Success rate

What's the Latest News About Fibrocell Science?

GlobeNewswireDecember 19, 2019

Castle Creek Pharmaceuticals Completes Acquisition of Fibrocell Science

Castle Creek Pharmaceuticals (now Castle Creek Biosciences) announced the completion of its acquisition of Fibrocell Science, Inc. This acquisition combined Fibrocell's late-stage gene therapy pipeline for rare skin diseases with Castle Creek's expertise in developing and commercializing therapies for dermatologic conditions....more

Fibrocell Science Press Release (via GlobeNewswire)September 26, 2019

Fibrocell Announces Positive Interim Data from Phase 1/2 Clinical Trial of FCX-007 for Treatment of RDEB

Fibrocell reported positive interim data from its Phase 1/2 clinical trial of FCX-007, an investigational gene therapy for recessive dystrophic epidermolysis bullosa, showing promising wound healing and safety profiles....more

FDA / Company ReleaseJune 22, 2011

Fibrocell Science, Inc. Receives FDA Approval for LAVIV® (azficel-T)

Fibrocell Science announced that the U.S. Food and Drug Administration (FDA) approved LAVIV (azficel-T), an autologous cellular product indicated for improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. This marked a significant milestone for the company in bringing an autologous cell therapy to market....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Fibrocell Science, are just a search away.